Sheel Biotech IPO

Incorporated in November 1991, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects. The company produces high-quality, disease-free planting materials for fruits, crops, vegetables, and ornamentals through tissue culture and organic farming. It also designs and maintains greenhouses, provides landscaping services, supports Farmer Producer Organizations, and offers training programs for skill development. Recognized by the Department of Biotechnology and the Department of Science and Technology, and holding ISO 9001:2015, 14001:2015, and 45001:2018 certifications, Sheel Biotech ensures quality, safety, and sustainable agricultural solutions.

Sheel Biotech Ltd. IPO Overview

Sheel Biotech IPO is a book-built issue with a total size of ₹34.02 crores, comprising entirely a fresh issue of 0.54 crore shares. The IPO opens for subscription on 30 September 2025 and closes on 3 October 2025, with allotment expected to be finalised on 6 October 2025. The shares will list on NSE SME, with a tentative listing date set for 8 October 2025. The price band is ₹59.00 to ₹63.00 per share, with a lot size of 2,000 shares. Retail investors need a minimum investment of ₹2,52,000 for 4,000 shares, while HNIs must apply for at least three lots, amounting to ₹3,78,000. Narnolia Financial Services Ltd. is the book running lead manager, and Skyline Financial Services Pvt. Ltd. is the registrar.

Sheel Biotech Ltd. IPO Details

Particulars	Details
IPO Date	30 September 2025 to 3 October 2025
Listing Date	8 October 2025
Face Value	₹10 per share
Issue Price Band	₹59 to ₹63 per share
Lot Size	2,000 Shares
Total Issue Size	54,00,000 shares (₹34.02 Cr)
Fresh Issue	54,00,000 shares (₹34.02 Cr)
Offer for Sale	NA
Issue Type	Bookbuilding IPO
Listing At	NSE SME
Shareholding Pre Issue	1,49,52,550 shares
Shareholding Post Issue	2,03,52,550 shares
Market Maker Portion	2,72,000 shares (₹1.71 Cr)

Sheel Biotech Ltd. IPO Reservation

Investor Category	Shares Offered
QIB	Not more than 50% of the Net Issue
Retail	Not less than 35% of the Net Issue
NII (HNI)	Not less than 15% of the Net Issue

Sheel Biotech Ltd. IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	2	4,000	₹2,52,000
Retail (Max)	2	4,000	₹2,52,000
HNI (Min)	3	6,000	₹3,78,000
HNI (Max)	7	14,000	₹8,82,000
B-HNI (Min)	8	16,000	₹10,08,000

Sheel Biotech Ltd. IPO Promoter Holding

Shareholding Status	Percentage
Pre-Issue	96.99%
Post-Issue	71.26%

Sheel Biotech Ltd. IPO Valuation Overview

KPI	Value
EPS (Pre IPO)	7.03
EPS (Post IPO)	1.43
P/E Ratio (Pre IPO)	8.96
P/E Ratio (Post IPO)	44.07
ROE	13.59%
ROCE	16.34%
Debt to Equity Ratio	0.32
EBITDA Margin	14.71%
Price to Book Value	1.26

Objectives of the Proceeds

• Capital expenditure requirement – ₹91.2 million

• Working capital requirement – ₹158.8 million

• General corporate purposes – amount as per board discretion

Key Financials (₹ Crores)

Particulars	31 May 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	105.98	105.95	93.89	93.08
Revenue	3.99	92.55	80.19	71.07
Profit After Tax	0.48	10.51	5.08	4.51
Reserves and Surplus	69.07	68.58	59.40	55.61
Total Borrowings	25.22	23.54	19.17	23.58